Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 64

1.

Tesevatinib ameliorates progression of polycystic kidney disease in rodent models of autosomal recessive polycystic kidney disease.

Sweeney WE, Frost P, Avner ED.

World J Nephrol. 2017 Jul 6;6(4):188-200. doi: 10.5527/wjn.v6.i4.188.

2.

Expanding the mutation spectrum in 130 probands with ARPKD: identification of 62 novel PKHD1 mutations by sanger sequencing and MLPA analysis.

Melchionda S, Palladino T, Castellana S, Giordano M, Benetti E, De Bonis P, Zelante L, Bisceglia L.

J Hum Genet. 2016 Sep;61(9):811-21. doi: 10.1038/jhg.2016.58. Epub 2016 May 26.

PMID:
27225849
3.

Hepatocyte Nuclear Factor 1β-Associated Kidney Disease: More than Renal Cysts and Diabetes.

Verhave JC, Bech AP, Wetzels JF, Nijenhuis T.

J Am Soc Nephrol. 2016 Feb;27(2):345-53. doi: 10.1681/ASN.2015050544. Epub 2015 Aug 28. Review.

4.

Long-term pulmonary function in children with recessive polycystic kidney disease.

Jahnukainen T, Kirjavainen T, Luoto T, Ylinen E, Linkosalo L, Arikoski P, Pakarinen M, Jalanko H.

Arch Dis Child. 2015 Oct;100(10):944-7. doi: 10.1136/archdischild-2015-308451. Epub 2015 Jul 10.

PMID:
26163120
5.

HNF1B-associated clinical phenotypes: the kidney and beyond.

Bockenhauer D, Jaureguiberry G.

Pediatr Nephrol. 2016 May;31(5):707-14. doi: 10.1007/s00467-015-3142-2. Epub 2015 Jul 8. Review.

PMID:
26160100
6.

Clinical manifestations of autosomal recessive polycystic kidney disease.

Hoyer PF.

Curr Opin Pediatr. 2015 Apr;27(2):186-92. doi: 10.1097/MOP.0000000000000196. Review.

PMID:
25689455
7.

HNF1B-associated renal and extra-renal disease-an expanding clinical spectrum.

Clissold RL, Hamilton AJ, Hattersley AT, Ellard S, Bingham C.

Nat Rev Nephrol. 2015 Feb;11(2):102-12. doi: 10.1038/nrneph.2014.232. Epub 2014 Dec 23. Review.

PMID:
25536396
8.

Transplantation in autosomal recessive polycystic kidney disease: liver and/or kidney?

Chandar J, Garcia J, Jorge L, Tekin A.

Pediatr Nephrol. 2015 Aug;30(8):1233-42. doi: 10.1007/s00467-014-2887-3. Epub 2014 Aug 13. Review.

PMID:
25115876
9.

Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects.

Hartung EA, Guay-Woodford LM.

Pediatrics. 2014 Sep;134(3):e833-45. doi: 10.1542/peds.2013-3646. Epub 2014 Aug 11. Review.

10.

Transcriptional complexity in autosomal recessive polycystic kidney disease.

Frank V, Zerres K, Bergmann C.

Clin J Am Soc Nephrol. 2014 Oct 7;9(10):1729-36. doi: 10.2215/CJN.00920114. Epub 2014 Aug 7.

11.

Consensus expert recommendations for the diagnosis and management of autosomal recessive polycystic kidney disease: report of an international conference.

Guay-Woodford LM, Bissler JJ, Braun MC, Bockenhauer D, Cadnapaphornchai MA, Dell KM, Kerecuk L, Liebau MC, Alonso-Peclet MH, Shneider B, Emre S, Heller T, Kamath BM, Murray KF, Moise K, Eichenwald EE, Evans J, Keller RL, Wilkins-Haug L, Bergmann C, Gunay-Aygun M, Hooper SR, Hardy KK, Hartung EA, Streisand R, Perrone R, Moxey-Mims M.

J Pediatr. 2014 Sep;165(3):611-7. doi: 10.1016/j.jpeds.2014.06.015. Epub 2014 Jul 9. No abstract available.

12.

Neurocognition in children with autosomal recessive polycystic kidney disease in the CKiD cohort study.

Hartung EA, Matheson M, Lande MB, Dell KM, Guay-Woodford LM, Gerson AC, Warady BA, Hooper SR, Furth SL.

Pediatr Nephrol. 2014 Oct;29(10):1957-65. doi: 10.1007/s00467-014-2816-5. Epub 2014 May 15.

13.

Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy.

Sweeney WE Jr, Avner ED.

Pediatr Res. 2014 Jan;75(1-2):148-57. doi: 10.1038/pr.2013.191. Epub 2013 Oct 31. Review.

14.

New approaches to the autosomal recessive polycystic kidney disease patient with dual kidney-liver complications.

Telega G, Cronin D, Avner ED.

Pediatr Transplant. 2013 Jun;17(4):328-35. doi: 10.1111/petr.12076. Epub 2013 Apr 17. Review.

15.

Combined liver-kidney transplantation for children with autosomal recessive polycystic kidney disease (ARPKD): indication and outcome.

Brinkert F, Lehnhardt A, Montoya C, Helmke K, Schaefer H, Fischer L, Nashan B, Bergmann C, Ganschow R, Kemper MJ.

Transpl Int. 2013 Jun;26(6):640-50. doi: 10.1111/tri.12098. Epub 2013 Apr 15.

16.

Intracranial aneurysm and recessive polycystic kidney disease: the third reported case.

Chalhoub V, Abi-Rafeh L, Hachem K, Ayoub E, Yazbeck P.

JAMA Neurol. 2013 Jan;70(1):114-6. doi: 10.1001/jamaneurol.2013.584.

PMID:
23318517
17.

Characteristics of congenital hepatic fibrosis in a large cohort of patients with autosomal recessive polycystic kidney disease.

Gunay-Aygun M, Font-Montgomery E, Lukose L, Tuchman Gerstein M, Piwnica-Worms K, Choyke P, Daryanani KT, Turkbey B, Fischer R, Bernardini I, Sincan M, Zhao X, Sandler NG, Roque A, Douek DC, Graf J, Huizing M, Bryant JC, Mohan P, Gahl WA, Heller T.

Gastroenterology. 2013 Jan;144(1):112-121.e2. doi: 10.1053/j.gastro.2012.09.056. Epub 2012 Oct 3.

18.

Congenital hepatic fibrosis in autosomal recessive polycystic kidney disease.

Wen J.

Clin Transl Sci. 2011 Dec;4(6):460-5. doi: 10.1111/j.1752-8062.2011.00306.x. Epub 2011 Dec 7. Review.

19.

Kidney and liver transplantation in patients with autosomal recessive polycystic kidney disease: a multicentric study.

Chapal M, Debout A, Dufay A, Salomon R, Roussey G, Burtey S, Launay EA, Vigneau C, Blancho G, Loirat C, Hourmant M, Fakhouri F.

Nephrol Dial Transplant. 2012 May;27(5):2083-8. doi: 10.1093/ndt/gfr588. Epub 2011 Nov 9.

PMID:
22076432
20.

Congenital hepatic fibrosis and portal hypertension in autosomal dominant polycystic kidney disease.

O'Brien K, Font-Montgomery E, Lukose L, Bryant J, Piwnica-Worms K, Edwards H, Riney L, Garcia A, Daryanani K, Choyke P, Mohan P, Heller T, Gahl WA, Gunay-Aygun M.

J Pediatr Gastroenterol Nutr. 2012 Jan;54(1):83-9. doi: 10.1097/MPG.0b013e318228330c.

PMID:
21694639

Supplemental Content

Support Center